Alvogen Completes Comprehensive Refinancing with Longer-Dated Maturity Profile and Reduction of Debt

The Consortium’s collective industry experience, geographical reach, and commitment to sustainable development, creates a unique alliance of investors and leaders, with the financial strength to support the companies continued development.

A powerful investment alliance of Aztiq and Innobic acquires Alvogen’s shares in Lotus and Adalvo in a US$475m deal

The new equity will allow Alvogen's generic business and its branded division Almatica Pharma to increase the R&D investment and expand branded sales channels in the US market.

Newly issued share equity in Alvogen US acquired by Aztiq Pharma Partners

The contribution will be used in UNICEF's participation in COVAX collaboration work in which the fund plays a key role in getting vaccines to over 90 low and middle income countries.

Alvogen and sister company Alvotech donate 100 thousand US dollars to UNICEF in combat against COVID-19

Alvogen is a global, privately owned pharmaceutical company focused on developing, manufacturing and selling generic, brand, and over-the-counter (OTC) products for patients around the world.

Setting a new standard for the future of pharma

Alvogen

Setting a new standard for the future of pharma

Alvogen News

Share